MARKSANS PHARMA
Back to Cashflow Statement
|
MARKSANS PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹458 Cr | ₹207 Cr | ₹230 Cr | ₹237 Cr | ₹99 Cr |
What is the latest Cash Flow from Operating Activities ratio of MARKSANS PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹458 Cr |
| Mar2025 | ₹207 Cr |
| Mar2024 | ₹230 Cr |
| Mar2023 | ₹237 Cr |
| Mar2022 | ₹99 Cr |
How is Cash Flow from Operating Activities of MARKSANS PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹458 Cr | 121.68 | |
| Mar2025 | ₹207 Cr | -10.30 | |
| Mar2024 | ₹230 Cr | -2.95 | |
| Mar2023 | ₹237 Cr | 139.19 | |
| Mar2022 | ₹99 Cr | - | |
Compare Cash Flow from Operating Activities of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹14,559.1 Cr | -3.1% | 30.3% | 79.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,090.0 Cr | 1% | -2.7% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,976.0 Cr | 0.7% | 17.1% | 40.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,639.0 Cr | -0.3% | -3.7% | 37.9% | Stock Analytics | |
| CIPLA | ₹115,216.0 Cr | -0.3% | 2.3% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | -1.4% | 0.7% | -6.2% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | -3.1% |
30.3% |
79.8% |
| SENSEX | -0.6% |
1% |
-3.7% |
You may also like the below Video Courses